4//SEC Filing
PF Equity Holdings 2 B.V. 4
Accession 0001883111-22-000001
CIK 0001737287other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:44 PM ET
Size
4.9 KB
Accession
0001883111-22-000001
Insider Transaction Report
Form 4
PF Equity Holdings 2 B.V.
10% Owner
Transactions
- Other
Common Stock
2022-03-31−22,032,040→ 0 total
Footnotes (1)
- [F1]Shares transferred to its parent entity, Pfizer Inc., for no cash consideration.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
IncorporatedNetherlands
Related Parties
1- filerCIK 0001883111
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:44 PM ET
- Size
- 4.9 KB